Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania

scientific article published on 26 June 2019

Analysis of the Indirect Costs of Rheumatoid Arthritis in Romania is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2019/9343812
P932PMC publication ID6617871
P698PubMed publication ID31346527

P50authorClaudiu PopescuQ56849440
P2093author name stringCătălin Codreanu
Corina Mogoșan
Marian-Sorin Paveliu
P2860cites workEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateQ26859134
Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.Q33332468
Willingness to pay for a quality-adjusted life year: in search of a standardQ33993542
Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007.Q34089998
Development of a matrix of cost domains in economic evaluation of rheumatoid arthritis.Q34215356
Treating rheumatoid arthritis to target: recommendations of an international task forceQ34462557
Cost-of-illness studies: concepts, scopes, and methodsQ34779725
Rheumatoid arthritis: direct and indirect costsQ35979186
A review of work-participation, cost-of-illness and cost-effectiveness studies in ankylosing spondylitisQ36611047
Comparison of informal care time and costs in different age-related dementias: a reviewQ36665371
Measuring Resource Utilization: A Systematic Review of Validated Self-Reported Questionnaires.Q37206940
Contact frequency, travel time, and travel costs for patients with rheumatoid arthritisQ37626996
The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates.Q41132306
Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing RheumatologistsQ41736186
Health consumer and patients' organizations in Europe: towards a comparative analysisQ42384174
Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.Q50622974
Direct cost of rheumatoid arthritis during the first six years: a cost-of-illness study.Q50634044
Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease.Q50672668
Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis.Q50708359
Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.Q50732154
Area of Residence and Socioeconomic Factors Reduce Access to Biologics for Rheumatoid Arthritis Patients in Romania.Q55100474
The economic impact of arthritisQ71010407
Costs and outcomes in rheumatoid arthritis and osteoarthritisQ71347965
The cost of rheumatoid arthritisQ71408295
Treatment of rheumatoid arthritis--does it affect society's cost for the disease?Q71408299
Economic consequences of the progression of rheumatoid arthritis in SwedenQ74456128
A multicenter cost-of-illness study on rheumatoid arthritis in ItalyQ74602775
Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritisQ79446069
Therapeutic criteria in rheumatoid arthritisQ80386526
Costs of rheumatoid arthritis in HungaryQ80435945
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectRomaniaQ218
rheumatoid arthritisQ187255
P304page(s)9343812
P577publication date2019-06-26
P1433published inBioMed Research InternationalQ17509958
P1476titleAnalysis of the Indirect Costs of Rheumatoid Arthritis in Romania
P478volume2019

Search more.